tiprankstipranks
Advertisement
Advertisement
Midday Fly By: Dominion to combine with NextEra, Publicis to acquire LiveRamp
PremiumThe FlyMidday Fly By: Dominion to combine with NextEra, Publicis to acquire LiveRamp
2M ago
Design Therapeutics reports positive Phase 1/2 DT-216P2 data
Premium
Company Announcements
Design Therapeutics reports positive Phase 1/2 DT-216P2 data
2M ago
Design Therapeutics announces biomarker, clinical data from RESTORE-FA trial
Premium
The Fly
Design Therapeutics announces biomarker, clinical data from RESTORE-FA trial
2M ago
Design Therapeutics price target raised to $21 from $18 at Oppenheimer
PremiumThe FlyDesign Therapeutics price target raised to $21 from $18 at Oppenheimer
2M ago
Design Therapeutics price target raised to $20 from $12 at Piper Sandler
Premium
The Fly
Design Therapeutics price target raised to $20 from $12 at Piper Sandler
2M ago
Design Therapeutics reports Q1 EPS (29c), consensus (33c)
Premium
The Fly
Design Therapeutics reports Q1 EPS (29c), consensus (33c)
2M ago
Design Therapeutics management to meet with Oppenheimer
PremiumThe FlyDesign Therapeutics management to meet with Oppenheimer
3M ago
Design Therapeutics Appoints David Shapiro to Board
Premium
Company Announcements
Design Therapeutics Appoints David Shapiro to Board
3M ago
Design Therapeutics initiated with a Buy at Jefferies
Premium
The Fly
Design Therapeutics initiated with a Buy at Jefferies
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100